ESGEN Acquisition Corp. (NASDAQ:ESAC) announced this morning that it has amended its combination with residential solar company Sunergy, shrinking its valuation while adding committed funding.
Under the revised terms of the transaction, ESGEN’s sponsor has committed to buying $15 million in convertible preferred equity securities. Of this amount, $10 million will be provided at the close of the combination, while the remaining $5 million may be funded at the discretion of the combined company within six months after closing. Energy Spectrum Partners VIII will finance the purchase of the Convertible Preferred Securities.
As a result, the enterprise value for the combined company has been lowered -17.8% to $390 million from $475 million, with the proceeds earmarked for operational and growth purposes.
Additionally, the sponsor and other insiders have agreed to forfeit 2,900,000 million founder shares upon closing, leaving 4,000,000 founder shares remaining. An extra 500,000 founder shares will also be forfeited if the convertible preferred securities are redeemed or if the sponsor converts them within two years of closing.
Lastly, all outstanding private placement warrants held by the sponsor and other insiders will be canceled upon the transaction’s closing.
ESGEN announced its deal with Sunergy in April and expects to complete the combination in the first half of 2024. The New Port Richey, Florida-based company installs home-based solar panel systems primarily in three Southern US states.
Terms Tracker for the Week Ending February 28, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. With four new IPOs pricing this week, February closes out with eight total IPOs, matching January’s count. That brings the year-to-date total to 16. Interestingly,...
Republic Digital Acquisition Company (NASDAQ:RDAGU) has filed for a $220 million SPAC to hunt for a target in crypto and blockchain technology. The underwriter will be Cantor, which has priced two IPOs so far this year and has four more on file to IPO including Republic Digital. The count of four “on file to IPO” ...
The crop of 13 SPAC sponsors and target companies coming loose from their lock-up agreements this month are representatives of some counter-narrative trends as the two best performing deals are Latin American companies on the eve of new tariffs and the lowest performers are those from the buzzy world of AI software applications. The deal...
Helix II (NASDAQ:HLXB) has entered into a definitive agreement to combine with cancer drug developer BridgeBio at an enterprise value of $360 million. San Francisco-based BridgeBio is developing a trio of potential treatments specifically targeting the KRAS mutation in some lung, breast, pancreatic, and colon cancers. The combined company is expected to trade on the...
At the SPAC of Dawn On a day that the market takes in more Core PCE inflation readings, SPAC watchers also have the chance to peruse the S-1 of yet another former SPAC target that is trying its luck at the traditional IPO path. Drone and aviation firm AIRO Group has not outlined its proposed...